New blood test that can detect 50 different types of cancer shows progress
A novel blood test that can detect for more than 50 types of cancer has shown promise to accelerate diagnosis and fast-track patients for treatment, according to results of a trial.
A novel blood test that can detect for more than 50 types of cancer has shown promise to accelerate diagnosis and fast-track patients for treatment, according to results of a trial.
The trial, conducted by the UK National Health Service, showed that the test correctly revealed two out of every three cancers among 5,000 people with suspected symptoms, the BBC reported.
In 85 per cent of those positive cases, it also pinpointed the original site of cancer. The test is particularly good at finding hard-to-spot cancers such as head and neck, bowel, lung, pancreatic, and throat cancers, revealed the results presented at the American Society of Clinical Oncology's annual meeting in Chicago.
Known as Galleri test, developed by the US-based company Grail, it is intended to detect a cancer signal and predict cancer signal origin to inform diagnostic evaluation.
The test looks for distinct changes in bits of genetic code that leak from different cancers. Spotting treatable cancer early can save lives.
Although not accurate enough to "rule in or rule out cancer", the test was really useful for patients, lead researcher Prof Mark Middleton told BBC News.
"The test was 85 per cent accurate in detecting the source of the cancer - and that can be really helpful because so many times it is not immediately obvious when you have got the patient in front of you what test is needed to see whether their symptoms are down to cancer," he said.
"With that prediction from the test, we can decide whether to order a scope or a scan and make sure we are giving the right test the first time."
"The findings from the study suggest this test could be used to support GPs to make clinical assessments - but much more research is needed, in a larger trial, to see if it could improve GP assessment and ultimately patient outcomes," Dr David Crosby, from Cancer Research UK, was quoted as saying.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
08:50 PM IST